These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1534366)

  • 21. Gait instability in valproate-treated patients: Call to measure ammonia levels.
    Kipervasser S; Elger CE; Korczyn AD; Nass RD; Quesada CM; Neufeld MY
    Acta Neurol Scand; 2017 Nov; 136(5):401-406. PubMed ID: 28436001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is 2-propyl-4-pentenoic acid, a hepatotoxic metabolite of valproate, responsible for valproate-induced hyperammonemia?
    Kondo T; Ishida M; Kaneko S; Hirano T; Otani K; Fukushima Y; Muranaka H; Koide N; Yokoyama M; Nakata S
    Epilepsia; 1992; 33(3):550-4. PubMed ID: 1350534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valproate-induced coma: case report and literature review.
    Duarte J; Macias S; Coria F; Fernandez E; Clavería LE
    Ann Pharmacother; 1993 May; 27(5):582-3. PubMed ID: 8347908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Valproate-induced hyperammonemia in asymptomatic children.
    Wyllie E; Wyllie R; Rothner AD; Erenberg G; Cruse RP
    Cleve Clin Q; 1983; 50(3):275-7. PubMed ID: 6418412
    [No Abstract]   [Full Text] [Related]  

  • 25. A case of severe hyperammonemia and unconsciousness following sodium valproate intoxication.
    Lee WL; Yang CC; Deng JF; Chen YF; Lin HD; Wang PH
    Vet Hum Toxicol; 1998 Dec; 40(6):346-8. PubMed ID: 9830696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal handling of carnitine in children with carnitine deficiency and hyperammonemia associated with valproate therapy.
    Matsuda I; Ohtani Y; Ninomiya N
    J Pediatr; 1986 Jul; 109(1):131-4. PubMed ID: 3088240
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Valproate-associated hyperammonemic encephalopathy. Report of one case].
    Young P; Finn BC; Alvarez F; Bruetman JE; Trimarchi H
    Rev Med Chil; 2007 Nov; 135(11):1446-9. PubMed ID: 18259656
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valproate-induced hyperammonemia as a cause of altered mental status.
    Feil D; Chuang K; Sultzer DL
    Am J Geriatr Psychiatry; 2002; 10(4):476-8. PubMed ID: 12095907
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Valproate hepatotoxicity: a review and report of two instances in adults.
    Dickinson RG; Bassett ML; Searle J; Tyrer JH; Eadie MJ
    Clin Exp Neurol; 1985; 21():79-91. PubMed ID: 3939614
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Valproate-induced hyperammonemic encephalopathy in a neonate: treatment with carglumic acid].
    Fernández Colomer B; Rekarte García S; García López JE; Pérez González C; Montes Granda M; Coto Cotallo GD
    An Pediatr (Barc); 2014 Oct; 81(4):251-5. PubMed ID: 24315420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Sodium valproate, hyperammonemia and hepatic encephalopathy].
    Imler M; Warter JM; Marescaux C
    Gastroenterol Clin Biol; 1982 Dec; 6(12):1042. PubMed ID: 6819177
    [No Abstract]   [Full Text] [Related]  

  • 32. Sodium valproate-induced hyperammonemia without clinical hepatic dysfunction.
    Zaret BS; Beckner RR; Marini AM; Wagle W; Passarelli C
    Neurology; 1982 Feb; 32(2):206-8. PubMed ID: 6798491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidental microvesicular steatosis due to valproic acid anticonvulsant therapy.
    Scott DA; Gholson CF; Netchvolodoff CV; Ray M; Gonzalez E; Bacon BR
    Am J Gastroenterol; 1991 Apr; 86(4):500-2. PubMed ID: 1901443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymptomatic hyperammonemia in patients receiving valproic acid.
    Murphy JV; Marquardt K
    Arch Neurol; 1982 Sep; 39(9):591-2. PubMed ID: 6810855
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Different clinical manifestations of hyperammonemic encephalopathy.
    Gomceli YB; Kutlu G; Cavdar L; Sanivar F; Inan LE
    Epilepsy Behav; 2007 Jun; 10(4):583-7. PubMed ID: 17412645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case report of valproate encephalopathy].
    Miyamoto T; Miyamoto M; Hirata K; Katayama S
    Rinsho Shinkeigaku; 1999 Oct; 39(10):1075-7. PubMed ID: 10655774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Valproate-induced hyperammonaemic encephalopathy: review of 14 cases in the psychiatric setting.
    Dealberto MJ
    Int Clin Psychopharmacol; 2007 Nov; 22(6):330-7. PubMed ID: 17917551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-convulsive status epilepticus secondary to valproic acid-induced hyperammonemic encephalopathy.
    Velioğlu SK; Gazioğlu S
    Acta Neurol Scand; 2007 Aug; 116(2):128-32. PubMed ID: 17661800
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Familial hyperinsulinism-hyperammonemia syndrome in a family with seizures: case report.
    de las Heras J; Garin I; de Nanclares GP; Aguayo A; Rica I; Castaño L; Vela A
    J Pediatr Endocrinol Metab; 2010 Aug; 23(8):827-30. PubMed ID: 21073125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A severe valproate overdose with complete recovery in a newborn.
    Grynnerup A; Fernández IS; Hernández JC; Martínez AD; López JM; García-Alix A
    J Child Neurol; 2012 Aug; 27(8):1072-6. PubMed ID: 22433424
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.